Related Experiment Video

Updated: Aug 16, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

The benefit of cholesterol-lowering medications after coronary revascularization: a population study

James M Brophy1, Paul Brassard, Chantal Bourgault

  • 1Department of Medicine, McGill University Health Center, McGill University, Montréal, Québec, Canada. james.brophy@mcgill.ca

American Heart Journal
|August 10, 2005
PubMed

Insights

Cholesterol-lowering medications significantly reduced mortality and myocardial infarction risk in elderly patients after coronary revascularization. These findings highlight the importance of statin therapy for secondary prevention in this population.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Cholesterol-lowering medications are proven effective for secondary prevention in coronary artery disease.
  • Benefits in elderly patients post-coronary revascularization are less understood in routine practice.

Purpose of the Study:

  • To evaluate the effectiveness of cholesterol-lowering drug therapy in elderly patients after coronary revascularization.
  • To assess the impact on total mortality, myocardial infarction, and repeat revascularizations.

Main Methods:

  • Utilized Quebec's administrative health databases to identify elderly patients (>65) post-revascularization (1995-1997).
  • Assessed cholesterol-lowering drug prescription fulfillment rates.
  • Employed time-dependent multivariable models to analyze clinical outcomes over a 3-year follow-up.

Main Results:

  • 11,958 elderly patients were included.
  • Cholesterol-lowering drug users showed a reduced risk of death (HR 0.66) and myocardial infarction (HR 0.77).
  • No significant reduction in repeat revascularizations was observed (HR 1.06).

Conclusions:

  • Cholesterol-lowering medications provide significant health benefits in elderly patients post-revascularization.
  • Observed benefits are comparable to those in clinical trials.
  • Emphasizes the critical role of these drugs in secondary prevention for a broader patient population.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...